Hanmin

Hangzhou Hanmin Pharmaceutical Technology is a specialized biotechnology firm based in Hangzhou, China, focused on the development of innovative small molecule therapeutics and high-end generic drugs. The company leverages a robust technology suite, including a proprietary deuteration platform and advanced crystal form screening, to optimize drug candidates for oncology and metabolic indications. In addition to its internal R&D programs, Hanmin operates as a CRO and CDMO, providing chemical synthesis and process development services to the global life sciences industry. The firm is designated as a National High-tech Enterprise and maintains a strong focus on intellectual property and quality-driven manufacturing. Its pipeline includes several innovative candidates in the pre-clinical stages alongside a portfolio of complex generic products.